News DexCom, Inc.

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 16/10/2026 BST			5-day change	1st Jan Change
86.04 ^USD	-1.90%		+2.29%	+29.64%

10-16	HEALTH ROUNDS-Glucose monitoring devices for type 2 diabetes benefit even those not on insulin	RE
10-14	DexCom, Inc. Announces Publication Of CONNECT Study Results For Dexcom G7 In The New England Journal Of Medicine	CI

All News

Mentions Relevance

10-14	Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin	BU
10-14	DexCom, Inc. Announces Publication Of CONNECT Study Results For Dexcom G7 In The New England Journal Of Medicine	CI
10-13	Mizuho Adjusts Price Target on DexCom to $100 From $95	MT
10-12	BTIG Adjusts Price Target on DexCom to $96 From $90	MT
10-07	Evercore ISI Adjusts Price Target on DexCom to $110 From $90	MT
10-07	Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time	BU
10-06	Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading	BU
10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
09-28	Dexcom Publishes New Report During Easd 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	CI
09-28	Tandem Diabetes Expands Insulin Delivery System to 12 New Countries	MT
09-28	Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	BU
09-17	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
09-16	Dexcom Insider Sold Shares Worth $679,769, According to a Recent SEC Filing	MT
09-14	DexCom Promotes CFO Jereme Sylvain to Additional COO Role	MT
09-14	Dexcom, Inc. Announces Appointment of Jereme Sylvain as Executive Vice President and Chief Operating Officer, Effective September 14, 2026	CI
09-14	Dexcom Promotes Jereme Sylvain to Chief Operating Officer	BU
09-14	Dexcom Insider Sold Shares Worth $302,936, According to a Recent SEC Filing	MT
09-10	DexCom, Inc. Announces Appointment of Glenn S. Boehnlein as Director, Member of Operations & Innovation Committee and Audit Committee, Effective September 10, 2026	CI
09-10	Dexcom Appoints Glenn Boehnlein to Board of Directors	BU
09-09	DexCom, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08:00 AM
09-01	Dexcom Announces Upcoming Conference Presentation	BU
08-24	Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing	MT
08-13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
08-04	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
08-03	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT